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ABSTRACT

ACCESSING THE BIOAVAILABILITY OF PHYTOCHEMICALS IN CACO-2 CELL
MODEL AND DEVELOPING A SENSITIVE METHOD FOR THE DETECTION
AND QUANTIFICATION OF THESE COMPOUNDS

SEPTEMBER 2012
HANÁ SHATARA SOBERS, B.S., PURDUE UNIVERSITY
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor H. Xiao

Numerous studies have found certain unmethylated phytochemicals to possess
anti-carcinogenic activity; however, they have been associated with poor oral
bioavailability which is a major limiting factor in their usage in chemopreventative
treatment. The purpose of this study was to investigate if methylation of a compound
would affect bioavailability, in terms of transport and permeability, in a Caco-2 cell
model as well as the effect of cell viability and cellular uptake in human colon cancer cell
lines. Furthermore, a new analytic method using reversed-phase high performance liquid
chromatography coupled with electrochemical detector (HPLC-EC) for the detection and
quantification of resveratrol and pterostilbene was developed.
This new method was simple, rapid, and more sensitive compared to other
detection methods used to analyze resveratrol and pterostilbene. Linear range, limit of
detection (LOD), precision and recovery were used to validate this new analytical
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method. There was a significant increase in intracellular uptake and stronger growth
inhibitory of pterostilbene in human cancer cells lines in comparison to resveratrol.
Resveratrol exhibited a higher and more rapid rate of transport than pterostilbene across
the Caco-2 monolayer regardless of the concentration tested and direction. Pterostilbene
exhibited little difference in the rate of transport from either direction. The HCT-116
colon cells had intracellular uptake of each of the polymethoxyflavones (PMFs) tested.
Transport was observed by all the PMFs and each had different rates of transport.
Overall, location and amount of methyl groups had an effect on bioavailablity of a
compound and these compounds show promise as chemopreventative agents.

Keywords: Resveratrol; Pterostilbene; Polymethoxyflavones (PMF); Caco-2
cells; Transport; Permeability; Bioavailability; Electrochemical (EC) detection
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CHAPTER 1
INTRODUCTION

1.1 Cancer

1.1.1 Statistics
According to the World Health Organization (WHO), cancer accounts for more
deaths worldwide than HIV/AIDs, malaria, and tuberculosis combined and will soon
surpass heart disease and stroke as the most prevailing cause of death globally (WHO,
2011). In the United States, one in every four deaths is due to cancer exceeded only by
heart disease. It is estimated that almost 1.65 million new cases of cancer will be
diagnosed this year alone in the United States.
The probability of an American male developing cancer over his lifetime is a one
in two while for woman it is a one in three likelihood. In the United States, the most
common cancer in men is prostate and for women, it is breast cancer; lung and colorectal
cancers are the second and third most common cancers in both men and women
(American Cancer Society, 2011). These staggering statistics has sparked a surge in
cancer research.

1.1.2 Definition
Cancer arises from the transformation of a normal cell into an abnormal cell that
divides without control. In general, this is a multistage process that advances from a precancerous lesion to malignant tumors. Cancer cells can invade and spread to other parts
of the body through the blood stream and lymph system. Even though cancer can develop
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in nearly any tissue of the body, each type of cancer has its distinctive features yet the
fundamental processes that generate cancer are similar in all forms of the disease. A
majority of all colon cells are adenocarcinomas, which produce and release mucus and
other fluids (Ruoslahti, 1996; Weinberg, 1996). Using natural occurring compounds has
materialized as a plausible approach for cancer management and prevention (FrancyGuilford and Pezzuto, 2008; Khan et al., 2008; Surh, 2003; Syed et al., 2007).

Figure 1.1 Cancer arises from a loss of normal growth control (National Cancer
Institute, 2012)
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1.1.3 Chemoprevention

Chemoprevention can be defined as managing cancer by which the disease can be
prevented, hindered or reversed via administration of one or more compounds of natural
and/or synthetic origin (Siddiqui et al., 2008; Sporn and Suh, 2002; Surh, 2003).
Numerous epidemiological studies have linked fruit and vegetable consumption with a
reduced risk of cancer (Aggarwal and Shishodia, 2006; Center et al., 2009; Gusman et al.,
2001; McCullough et al, 2011). Multiple phytochemicals have been identified as
potential cancer fighting agents and subsequently, resulted in an explosion in the
supplement market selling these compounds to prevent cancer.
There are different ways to approach the use of phytochemicals as
chemopreventive agents. One method would be to incorporate foods rich with that
compound into ones diet. A whole food approach exist all ready for other disease and
aliments such as the use of soy base foods to reduce osteoporosis and cardiovascular
disease (Karp et al., 2007; Scheiber et al., 2001). Another approach would be to put the
phytochemical in a tablet or a power. Overall chemoprevention can be an easier and
cheap strategy to manage cancer in comparison to the more traditional methods (Eg.
Chemotherapy, Organ Removal).

1.2 Phytochemicals

1.2.1 Methylated vs. Unmethylated
A phytochemical can be defined as any chemical that is produced naturally by a
plant. Many phytochemicals, in particular flavonoids and stilbenes, are plant metabolites
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deriving from the phenlypropadnoid metabolism and shikimate pathways with a small
number of exceptions (Stafford, 1990; Watts et al., 2006). Unmethylated phytochemicals
have been studied most extensively (Pan and Ho, 2008; Walle et al., 2007).
Even though unmethylated phytochemicals have the potential to be great
candidates as chemoprevention agents, they have been associated with poor oral
bioavailability, which is a major limiting factor in their potency and usage as an additive
in food products. These compounds have low bioavailability because of the free
hydroxyl groups which gives rise to rapid intestinal/hepatic conjugation and/or sulfation
and excretion (Wen and Walle, 2006). The methylation of the free hydroxyl group(s) on
compound leads to a reduction in susceptible to glucuronic acid or sulfate conjugation,
resulting in improved metabolic stability (Walle, 2007). There is also an improved
transport through biological membranes (like intestinal absorption) and an increase in
oral bioavailability because of methylation (Walle, 2007; Wilson et al., 2008). Walle and
others (2007) have observed an increase in effectiveness by methylated compounds to
inhibit cancer cell growth. Despite being present in nature and their great potential in
cancer prevention, they lack the anti-oxidant effects that are usually linked with free
hydroxyl groups.

1.2.2 Polymethoxyflavones
Polymethoxyflavones (PMFs) refer to a distinctive class of flavonoinds
containing two or more methoxy groups on benzo-γ-pyrone skeleton (C6-C3-C6) with a
carbonyl group at the C4 position. In nature, PMFs are present exclusively in the citrus
genus, particularly in the peel of mandarin oranges (Citrus reticulata) and sweet oranges
(Citrus sinensis). Cultivation of citrus is thought to have begun around 4,000 years ago
4

in Southeast Asia and moved gradually west to Northern Africa, the Mediterranean, and
then to southern Europe by the Middle Ages (Bruening et al., 2010). In traditional
Chinese medicine, they have used citrus peel to treat and alleviate a wide range of
aliments like respiratory infections, indigestion and ringworm infections (Ou, 1999).
More than 20 PMFs have been isolated and identified from different tissues of citrus
plants (Li et al., 2006). (See Table 1.1 for a complete list of all the PMFs that were
utilized in this thesis).
The projected forecast for 2012, as of July 2012, on the global production of
oranges is 51.1 million metric tons (MMT) and 22.6 MMT for tangerine/mandarin. In
the United States, the predicted quantity is 8.1 MMT for productions of oranges and
slightly more than 0.5 MMT for tangerine/mandarin. Most of the tangerine/mandarin
produced are expected to be entirely consumed leaving only about 6% for processing. Of
the oranges grown worldwide, an estimated 28.5 MMT will be consumed leaving the
remaindering amount for processing, which is expected to be approximately 22.2 MMT.
An anticipated 2.2MMT of orange juice will be produced worldwide which will yield a
considerable amount of orange peel by-product that could potentially be used for medical
purposes (USDA: Foreign Agricultural Service, 2012).
PMFs have been shown to exhibit an expansive range of biological activities,
including anti-atherogenic (Whitman et al., 2005), anti-inflammatory (Chen et al., 2007;
Choi et al., 2007; Manthey et al, 2001; Middleton et al., 2000) and anti-oxidant (Li et al.,
2007a). PMFs have recently received a lot of attention because they have been shown to
have greater anti-carcinogenic activity than other flavones (Li et al., 2007a; Xiao et al.,
2009).
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Tangeretin, one of the most copious PMFs in citrus peels, has widely been
accepted has having excellent anti- carcinogenic activity (Chen et al., 2007; Morley et al.,
2007). Sergeev and his colleagues (2006) demonstrated that both PMF3 and PMF4
induce apoptosis by raising the amount of intracellular Ca2+ resulting from the depletion
of the Ca2+ endoplasmic reticulum and infux of Ca2+ from the extracellular space in
human breast cancer cell. Pan et al. (2007) observed induced growth inhibition of human
cancer cells by PMF4 as well as induction of apoptosis in human promyelocytic leukemia
cells through modulation of mitochondrial functions by PMF4. There has however been
a lag in the investigation on the bioavailability of PMFs.
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Table 1.1 PMFs used in the different experiments

Tan
(Tangeretin)

5,6,7,8, 4’ –
penamethoxyflavone

C20H20O7

Molecular
Mass
(g/mol)
372

PMF1
(Nobiletin)

5,6,7,8, 3’,4’ –
hexamethoxyflavone

C20H19O8

402

PMF2

3,5,6,7,8, 3’,4’ –
heptamethoxyflavone

C22H24O9

432

PMF3

5 – hydroxyl –
6,7,8,3’,4’ –
pentamethoxyflavone

C20H20O8

388

PMF4

5 – hydroxyl –
3,6,7,8,3’,4’ –
hexamethoxyflavone

C21H22O9

418

PMF5

5 – hydroxyl – 6,7,4’
– trimethoxyflavone

C15H13O6

328

PMF6

5-hydroxyl 3,6,7,3’,4’ –
pentamethoxyflavone

C20H19O8

388

PMF7

5- hydroxyl-6,7,8,4’
–tetramethoxyflavone

C19H16O7

358

Abbreviation

Structure

Name
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Molecular
Formula

1.2.3 Stilbenes

The word stilbene was derived from the Greek word stilbos, which means shining
(Likhtenshtein, 2010). Stilbenes are small molecular weight compounds (between 200 to
300 g/mol) produced in response to excessive ultraviolet exposure; microbial, fungal or
viral attack; or injury (Fauconneau et al., 1997). They are created by means of the
phenylpropanoid pathway, using phenylalanine ammonia lyase, cinnamate-4hydroxylase, stilbene synthase and 4-Coumarate-CoA ligase. The core chemical structure
of stilbene compounds is 1,2-diphenylethylene (Watts et al., 2006). They are found in a
wide range of plants and fruits, including Vitis and Vaccinium berries (Rimando et al.,
2004.) Stilbenes have been shown to possess a wide range of biological activities such as
anti-inflammation (Garodia et al., 2007; Juan et al., 2008; Ndiaye et al., 2011) and anticarcinogenic (Chillemi et al., 2007; Rimano and Suh, 2008).

8

A)

A
)

B
B)

)

Figure 1.2 Chemical structure of (a) resveratrol and (b) pterostilbene.

1.2.3.1 Resveratrol
Resveratrol (3,4’,5-trihydroxy-trans-stilbene) (Figure 1.2B) is the most
extensively investigated stilbene. They can be found in foods like berries, grapes and
peanuts (Rimando et al., 2004). There has been a long held notation that resveratrol from
red wine is responsible for “French Paradox”. It was back in the 1819 when an Irish
doctor, Samuel Black, first noticed that the French ate a lot of fatty foods yet stayed
healthy. This epidemiological phenomenon is that the French population has a drastically
lower incidence of cardiovascular disease than other developed countries despite having a
diet high in saturated fats. The French drink a lot of red wine, which resveratrol is a
major component (Kopp, 1998; Vidavalur et al., 2006). Numerous studies have shown
that resveratrol has the ability to block human platelet aggregation and eicosaoid
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snythesies, which may lower the chances of one developing cardiovascular disease
(Bertelli et al., 1995; Pace-Asciak et al., 1995; Yoshiyuki et al., 1985).
Each year, hundreds of studies are published on the therapeutic activities of
resveratrol ranging from an anti-oxidant (Bhat and Pezzuto, 2002; Chanvitayapongs, et
al. 1997) to anti-tumoural (Bishayee, 2009; Jang et al. 1997). It has also been shown to
be a powerful anti-carcinogenic agent because of its low toxicity and capability of
modulating numerous molecular pathways involved in cancer progression (Athar et al.,
2009). These pathways play a key role in anti-apoptosis, angiogenesis, cell cycle
progression and tumor invasion. In a mouse study executed by Cui et al. (2010), they
reported significant reduction in the incidence and multiplicity of tumors when mice were
feed resveratrol. They demonstrated that resveratrol can abate colitis; therefore, decrease
the potentially for colon cancer associated with colitis. In ovarian cancer cells,
resveratrol has been shown to cause apoptois, cell cycle arrest and detachment (Raj et al.,
2008). Jang et al. (1997) demonstrated the capability of resveratrol to block the
development of skin cancer at initiation, promotion and progression stages. Resveratrol
has also been showed to suppressing cancer progression in other cancers like breast,
gastrointestinal tract, lung and prostate (Bishayee, 2009).
Despite all the accolades resveratrol has received as a cancer chemopreventive
agent, it has a low systemic bioavailability due to it metabolizing rapidly once it is
ingested (Asensi et al., 2002; Delmas et al., 2011; Walle, 2011), which may lessen its
efficacy in humans. Therefore, there has been great effort to consider resveratrol
derivatives, which may have better bioavailability profiles.
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1.2.3.2 Pterostilbene
Pterostilbene (trans-3,5-dimethoxy-4’-hydroxystilbene) (Figure 1.2A), a naturally
dimethylether analogue of resveratrol, has recently gained a upsurge of interest because it
has been shown to have similar biological activities as resveratrol (Rimando et al., 2002).
It has been proven to be as effective as resveratrol in successfully inhibiting the
carcinogensesis in mice epidermis. They were both also able to decreased the expression
and activity of COX-2 and inducible nitric oxide synthase (iNOS) (Cichocki, 2008).
In an in vitro study done on human gastric carcinoma cells, pterostilbene caused
cell cycle arrest and induced apoptosis (Pan et al., 2007). Pterostilbene was capable of
suppressing aberrant crypt foci (ACF) formation, which occurs prior to colorectal
polyps. ACF is one of the earliest transformation observed in the colon that might lead to
cancer (Suh et al., 2007). Other studies have shown pterostilbene has the potential to
prevention and treatment of other cancers like breast, liver and lung (Alosi et al., 2010;
Pan et al., 2009; Schneider et al., 2010). In a side-by-side comparison of the effects of
resveratrol and pterostilbene on human colon cancer, pterostilbene had stronger
apoptosis-inducting effect and was more potent in inhibiting colony formation than
resveratrol (Nutakul et al., 2011). Methlyation may play a part in why there are these
stark differences. From all the research thus far, pterostilbene is an appealing candidate
for cancer prevention and treatment.
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1.3 Bioavailability

1.3.1 Overview
The bioavailability is an overall result of absorption, distribution, metabolism and
excretion (ADME).


Absorption describes a compound’s capability to pass into the systemic
circulation following oral administration.



Distribution explains how well a compound reaches the target tissue.



Metabolism is the rate that a nutrient/compound is eliminated from the
systemic circulation, following its initial absorption.



Excretion is the rate that a compound is excreted from the systemic
circulation and ultimately the body.

Figure 1.3 provides a graphic depiction of the bioavailability/ADME process.
Thus, bioavailability is determined by the combination of the rates of all these factors.
The bioavailability of a compound can therefore be defined as the amount of
nutrient/compound that reaches the blood circulation system and ultimately the target
tissue. Therefore, only the unbound fraction of a compound will reach the target tissue to
be able to interact with the molecular target (Balani et al., 2005; Van de Waterbeemd et
al., 2003).
Since oral administration is a widely employed method for the delivery of drugs
and foods, the effectiveness of a compound is dependent on their intestinal absorption to
get into systemic circulation to subsequently reach the intented tissue. The intestinal
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epithelium is a key determinant for the oral absorption of ingested pharmaceuticals, food
ingredients and toxins (Tong and Wen, 2008).

Figure 1.3 Overview of Bioavailability and ADME (Bourne, 2010).

Usually the first sets of experiments executed to understand the bioavailability of
a compound are absorption studies (Figure 1.4.). Permeability measures the ability and
velocity of a compound to cross through the intestinal membranes into the blood
circulation system. Permeability denotes the overall effects of influx and efflux in the
body. Intestine like cells such as Caco-2 cells can be used to predict permeability.
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Figure 1.4 Determinants of oral bioavailability and a decision-tree to assess their
role (Borchardt, 2006 ).

1.3.2 Bioavailability of Compounds of Interest
There have been a scarce number of investigations on the bioavailability of PMFs.
There have been more studies done on the solubility of PMFs which is a key factor when
accessing the absorption and bioavailability of PMFs but it alone doesn’t provide a
complete picture on overall bioavailability. When Murakami and his colleagues (2001)
conducted an in vitro study using Caco-2 cell monolayer to evaluate the absorption of
PMF1 and luteolin (unmethlyated PMF), more PMF1 was transported to the basolateral
compartment than luteolin after 4 hours. Also, PMF 1 accumulated in the Caco-2 cell
monolayer while luteolin did not. They concluding PMF 1 had higher permeability.
An in vivo study was also carried out on the same two compounds by Murakami
et al. (2002). Each compound was given independently by gastirc intubation to male rats
SD and after 1, 4 and 24 hours of administration, the concentrations were calculated.
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There results revealed that during the 1 to 4 hour periods, PMF1 was detected in stomach,
small and large intestines, kidney and liver; in contrast, luteolin was predominantly
detected in the gastrointestinal tract of the rats during 1 to 4 hour period following a
single dose administration. Also, PMF 1 tended to be localized in the mucous membrane
and muscularis at 1 and 4 hours time marks. Overall, PMF 1 had a wider distribution and
accumulation in tissues.
Numerous in vitro and in vivo studies on absorption, transport and bioavailability
have been done on resveratrol but not significant amounts have been conducted on
pterostilbene. Kapetanvico et al. (2011) demonstrated that when pterostilbene and
resveratrol were administered orally to rats, pterostilbene and resveratrol were
approximately 80% and 20% bioavailable, respectively. Pterostilbene had greater
bioavailability and total plasma levels of both parent compound and metabolites than
resveratrol. These differences are a hint that the in vivo biological activity of
pterostilbene might be greater than that of resveratrol. Also, suggesting that methlyation
may affect bioavailability.
Walle and his colleagues at Medical University of South Carolina have conducted
a number of studies comparing bioavailability of unmethyalted and methylated
flavoniods. In one study, they showed a 5 to 8 fold higher rate of intestinal permeability
by methylated flavonoids compared to their corresponding umethlyated counterpart
(Walle et al., 2006). In another study, again they demonstrated methylated compound had
better absorption and high oral bioavailability as well as tissue accumulation in vivo in
the rats (Walle et al., 2006).
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1.3.4 Caco-2 cell Monolayer Model
Caco-2 cell monolayers have been extensively used for years as a tool to test
permeability, assess the oral absorption potential and study the absorption mechanism of
compounds (Gan et al., 1993). Caco-2 cells originate from human colonic
adenocarcinoma cell lines. Typically after 21 days of growth, the Caco-2 cells
differentiate into a monolayer with micro villus structures and many other biochemical
and functional characteristics of small intestinal villus epithelium. The cells form tight
junctions, express many brush border enzymes, some CYP isosnzymes, and phase II
enzymes (such as glucuronidase, glutathione-S-transferases and sulfotranserase)
(Hubatsch et al., 2007; Lind et al., 2007).

Figure 1.5 Diagram of the Caco-2 cell monolayer cultivated on a permeable filter
support. Test compound is place on the apical or basolateral compartments. (Hubatch et
al., 2007).
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In the transport/permeability experiments, Caco-2 cells are cultivated on
permeable filters in which they represent the intestinal environment in that lumen is
separated from the bloodstream by the intestinal epithelial monolayer (Figure 1.5). Transepithelial passage of molecules from the apical to the basolateral side of the monolayer
can be easily measured in different experimental conditions, thus allowing discriminating
factors involved in transport mechanisms. To better mimic what is happening in the
body, different pH solutions can be used in each compartment. A pH of 6.5 can be used
in apical compartment to represent the pH of the upper small intestine under fasted
conditions while a pH of 7.4 can be used in the basolateral compartment to replicate the
pH of blood in the body (Deferme et al., 2008; Fallingborg, 1989; Lind et al. 2007).

Figure 1.6 Possible compound transport pathways across the intestinal mucosa,
illustrating (1) transcellular and (2) paracellular modes of passive transport, (3)
transcytosis, (4) carrier-mediated transport, and (5) efflux transport. A combination of
these routes often defines the overall transepithelial transport rate of nutrients and drug
(Deferme et al., 2008).
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Caco-2 cell monolayer expermients provide valuable information regarding (i)
intestinal permeability, (ii) transport mechanisms - paracellular, transcellar or active
carrier (Figure 1.6), (iii) role of intestinal metabolism and (iv) influence of p-glycoproetin
efflux system. There are potentially three datasets that can be obtained from the Caco-2
cell experiments and they are the following:


The apparent permeability (Papp) from apical compartment to the
basolateral compartment represents the overall effect of transportation
carried out by both absorptive transporters and secrectory transporters.



The apparent permeability (Papp) from basolateral compartment to apical
compartment measures the effects of secretory transporters only.



The ratio of Papp from basolateral compartment to apical compartment
over the Papp from apical compartment to the basolateral compartment
evaulates efflux. If the ratio is greater than 3, then there is a greater
possible of efflux will occur. This means a compound is being pumped
out too quickly from the blood circulation system, which will have an
effect on the amount of compound in the sytemtic circulation and thus
affect the absorption and bioavailability of the compound.

Therefore, Caco-2 cell model experiments offer vital insight in the prelimianry
phase of compound discovery on intestinal permeability, transport, absorption through
membrances and overall potential bioavailiablity (Walle et al., 2003) .
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CHAPTER 2
RAPID METHOD FOR THE DETERMINATION OF RESVERATROL AND
PTEROSTILBENE BY REVERSED-PHASE HIGH PERFORMANCE LIQUID
CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION

2.1 Abstract
Resveratrol (3,5,4’-trihydroxy-trans-stilbene) and pterostilbene (trans-3,5dimethoxy-4’-hydroxystilbene) both belong to the stilbene family. They have an array of
pharmacological properties from anti-atherosclerosis to anti-carcinogenic. The aim of
this study was to develop a simple, rapid and highly sensitive method using reversedphase high performance liquid chromatography (HPLC) equipped with an
electrochemical (EC) detector for the quantification of resveratrol and pterostilbene. The
developed analytical method was fully validated in terms of accuracy, linearity and
precision. The recovery rates were between 96.59% and 109.01%. Both calibration
curves showed excellent linearity with correlation coefficient (r2) greater than 0.999. The
limit of detection (LOD) values was lower than those obtained by other detectors
published in the literature. The precision for the retention times and peak areas were both
below 9%. The method was applied to quantify resveratrol and pterostilbene from
commercial juice products. The proposed method could be useful for prospective
nutritional, pharmacological and toxicological research on resveratrol and pterostilbene.

Keywords: Resveratrol; Pterostilbene; Stilbene; High performance liquid
chromatography (HPLC); Electrochemical detection (EC)
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2.2 Introduction
Stilbenes, a small family of polyphenolic compounds, have received increased
attention over the past decade due to their array of pharmacological properties, including
anti-atherosclerosis (Ko et al., 1999; Luo et al., 2008, Pace-Asciak et al., 1995) and anticarcinogenic activity in various biological systems (Namasivayam, 2011; Paul et al.,
2010; Rimano and Suh, 2008). Of all the stilbenes, resveratrol (3,5,4’-trihydroxy-transstilbene) has been most extensively investigated for its potential health benefits to
humans such being anti-oxidant (Gescher, 2008; Rimando and Suh, 2008). Despite all
the accolades resveratrol has received, it has low systemic bioavailability (Asensi et al.,
2002; Delmas et al., 2011; Walle, 2011), which may lower its efficacy in humans;
therefore, has lead researchers to investigate resveratrol derivatives.
Pterostilbene (trans-3,5-dimethoxy-4’-hydroxystilbene), a dimethylether analogue
of resveratrol, has been shown to have anti-carcinogenic (Paul et al., 2010; Tolomeo et
al., 2005), anti-diabetic (Amarnath and Pari, 2006; Pari and Satheesh, 2006; Szkudelski
and Szkudelska, 2011) and anti-inflammatory activity (Remsberg et al., 2007). In some
cases, it possesses stronger inhibitory activity (Billack et al., 2008; Huang et al., 2007;
Paul et al, 2010;) and overall better pharmacokinetic characteristics than resveratrol (Lin
et al., 2009).
Numerous analytical techniques have been proposed for the separation,
identification, and determination of stilbenes. Researchers overall prefer the employment
of high performance liquid chromatographs (HPLC) for qualitative and quantitative
measurements of resveratrol and pterostilbene (Buiarelli et al., 2006; Gocan, 2009;
Kolouchová-Hanzlíková et al., 2004; Rodríguez-Bernaldo de Quiró et al. 2007). When
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compared to other systems, HPLC has higher resolution, columns that can be used again
without regeneration or repacking and quicker cycle times. Furthermore, the mobile
phase of these systems can be varied during the analysis producing a gradient elution.
HPLC coupled with UV detector is the most prevalently used for quantification of
stilbenes (Dong, 2005; Lin et al., 2009); however, HPLC coupled with mass spectrometry
(MS) and fluorescence (FL) detectors are also commonly used (Buiarelli et al., 2006,
Remsberg et al., 2007) for detection of stilbens.
Because of its high selectivity and excellent sensitivity, HPLC with
electrochemical (EC) detector has become more popular in the determination of stilbenes
in complex matrices (Jandera et al., 2005; Benova et al., 2008). EC detector does not
exploit a physical property of an analyte, like UV and fluorescence detectors, but induce
a chemical change that results from an electrochemical reaction. EC has the ability to
detect resveratrol in the low pg range (Gocan, 2009). However, in the literature, there are
few validated analytical methods, if any, for the determination of pterostilbene with
HPLC-EC using a multichannel arrary.
In this study, a validated HPLC method with multi-channel EC detection was
developed for the quantitative analysis of resveratrol and pterostilbene. The capability of
the HPLC system was evaluated with the following factors: peak shape, linearity,
detection limits, accuracy, recovery and precision. Potentials of electrodes and mobile
phase were also evaluated to see how they can aid in optimizing the analytical conditions.
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2.3 Materials and Methods

2.3.1 Chemicals and reagents
All organic solvents utilized, acetonitrile (ACN), methanol (MeOH),
tetrahydrofucan (THF), trifluoroacetic acid (TFA) were of HPLC grade and purchased
from Fisher Scientific (Fairlawn, NJ, USA). Ammonium Acetate (99%) was purchased
from EMD Chemicals Inc. (Gibbstwon, NJ, USA). Highly purified trans-resveratrol
(99%) and pterostilbene(98%) were obtained from Quality Phyochemical LLC (NJ,
USA).

2.3.2 Instrumentation
The CoulArray® HPLC system was obtained from ESA (Chelmsford, MA, USA)
and equipped with a binary solvent delivery system (model 584), an auto-sampler (model
542), a CoulArray® Multi-Channel EC detector (model 6210 - two cells, each cell
contains four channels), and a UV detector. Data collection, processing and instrument
control were achieved using the CoulArray 3.06 software.

2.3.3 Chromatographic Conditions
Ascentis RP-Amide reversed-phase HPLC column (15 cm x 4.6 mm id, 3 µm)
from Sigma-Aldrich (St. Louis, MO, USA) was used to analyze compounds. The mobile
phase consisted of 50% water, 40% ACN, 10% THF and 50mM ammonium acetate.
The pH of the mobile phase was adjusted with TFA to achieve a pH range between 3.5 to
3.8. Mobile phase was filtered through a 0.45µm membrane filter from Millipore
(Bedford, MA, USA). Both EC detector cells (each contains four channels) were used
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and detection potentials were set at 200, 300, 400, 500, 600, 700, 800 and 900 mV. The
temperature of the auto-sampler was set to 4°C. The flow rate was set to 1.0 ml/min.

2.3.4 Preparation of standards
The stock solution of each compound was prepared in DMSO. These solutions
were protected from light and stored in the darkness at 4°C when not in use. The
concentrations ranges for both compounds were between 0.001 and 10µL and were
prepared by a serial of dilution with 50% MeOH just before each experiment. A 10µL
volume was injected in the HPLC.

2.3.5 Analyses of Juice Samples
A total of 6 juices (2 Grape Juices, 2 Blueberry Juices, and 2 Mix Fruit Juices)
were analyzed. They were purchased from local supermarkets (Amherst, MA, USA). A
volume of 400µL of juice and 100 µL MeOH were votexed together for 1 minute. The
juice/MeOH mixture was extracted with equal volume of ethyl acetate for a total of three
times. The ethyl acetate collected was pooled together and evaporated to dryness.
Samples were reconstituted in 400µL 50% MeOH and analyzed using the HPLC-EC
method developed in this study to determine the amount of resveratrol and pterostilbene
in each sample.
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2.4 Results and Discussion

2.4.1 Optimization of Chromatographic Conditions
The aim of this study was to achieve in a single HPLC run the separation of
resveratrol and pterostilbene in a respective short period of time with relatively simple
gradient profile. This method was able to successfully attain this goal. A representative
chromatogram of resveratrol and pterostilbene at various potentials is illustrated in Figure
2.2.
Mobile phase with water-MeOH-THF and water-ACN-THF using the same
gradient profile were evaluated. It was determined that the mobile phase composed of
water-ACN-THF attained superior resolution and better retention time than the waterMeOH-THF mobile phase. There were no interfering peaks co-eluted from the mobile
phase or with compounds of interest. ACN was also selected as the organic solvent of
choice over MeOH due to issues with high pressure associated with MeOH as a solvent.
EC detector is a very sensitive detector that can be effected by the ph and ionic strength
of the buffer system in the mobile phase (Benova et al., 2008). Therefore, ammonium
acetate was added to stabilize the pH value of mobile phase. The retention time of
resveratrol and pterostilbene were around 4 and 12.5 minutes, respectively. After
evaluation, the optimal conditions were achieved with mobile phase of water-ACN-THF
(50:40:10, v/v/v) containing 50mM ammonium acetate and the flow rate of 1.0 ml/min.
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Resveratrol

Pterostilbene

(µA)

Response

(300mV)

4.0

8.0

12.0

Retention time (minutes)
Figure 2.1 Representative chromatograms of resveratrol and pterostilbene at
different potentials. Potentials with dominant peaks of compounds are noted on the
figure.
2.4.2 Voltametric Behavior of Resveratrol and Pterostilbene
The electrochemical detection offers different and reproducible signal responses
to a compound at the oxidation or reduction potential applied across the individual flowthrough cells connected in series. The correlation between potential utilized on
electrochemical cells and the peak area of the target compound was evaluated. Each
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stilbene was subject a series of electric voltages in 100mV increments on EC detector
concurrently for HPLC analysis. This allowed for the study to establish optimal potential
for resveratrol and pterostilbene based on the observed voltametric behavior of the
compounds.
Table 2.1 highlights the ratios of pre/postdominant peak area and electrochemical
cell potential of the dominant peak of each compound. The dominant peak area
corresponds with the electrochemical cell potential generating the maximum intense
signal. The predominant and postdominant peak areas were designated as the signals of
the detection cells preceding and succeeding the dominant peak area channel,
respectively. As depicted in Figures 2.1 and 2.2, for both resveratrol and pterostilbene,
the electric voltage of 300mV generated the largest peak.
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Figure 2.2 The effect of electrochemical cell potential on the peak area (µC) for
(a) resveratrol and (b) pterostilbene. The concentration for each compound was 5µM.
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Table 2.1 Voltametric behavior of resveratrol and pterostilbene.
Compound
Potential of the
Ratio of Peak Areaa
Dominant Peak
Predominant
Postdominant
(mV)
Resveratrol
300
0.14
0.04
Pterostilbene
300
0.36
0.33
a. The ratios are associated with the dominant peak area of the compound of interest.
2.4.3 Linearity and Range
The linearity of the detector response was assessed by analyzing the calibration
graphs of resveratrol and pterostilbene. The graphs were constructed based on plotting
the peak area of the compound of interest against the corresponding concentrations.
Linear regression analysis was used to determine the linearity of the analytical method.
Table 2.2 lists the regression equations and correlation coefficients (r2) for
resveratrol and pterostilbene. The concentration range between 0.001µM and 10 µM
were utilized. The correlation coefficients (r2) were greater than 0.999 for both resveratrol
and pterostilbene indicating good linearity for the tested concentration ranges for each
compound.
Table 2.2 Linearity, LOD, and LOQ for resveratrol and pterostilbene.
Compound
Concentration Linear regression equation Correlation
range (µM)
coefficient,r2
Resveratrol
0.001 - 10
y = 4368.9x + 77.696
0.9997

LOD
(ng/ml)
0.29

LOQ
(ng/ml)
1.0

Pterostilbene

2.0

6.7

0.001 - 10

y = 4530.1x + 71.95
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0.9996

2.4.4 LOD and LOQ
The limit of detection (LOD) and limit of quantification (LOQ) were calculated
based on method outlined by the International Conference of Harmonisation (ICH 2005).
The LOD was defined by lowest measured concentration that can be detected above
baseline nose with a signal-to-noise (S/N) ratio of 3:1. Similarly, the LOQ was
determined S/N of 10:1.
As indicated in Table 2.2, pterostilbene had higher LOD and LOQ values than
resveratrol. The LOD and LOQ values presented here were lower than values acquired
from other HPLC with EC detector (Benova et al., 2008; Kolouchová-Hanzlíková et al.,
2004) as well as to usage of other detectors like FL and UV (Buiarelli et al., 2006; Gocan,
2009; Rodríguez-Bernaldo de Quirós et al., 2007). For resveratrol, this method had LOD
value that was at least 100 times lower than with UV detection (Vian et al., 2005). Also,
the LOD and LOQ values for pterostilbene in this study were lower than those obtained
by other detectors published in the literature (Remsberg et al., 2007; Lin et al., 2009).

2.4.5 Accuracy/Recovery Studies
The accuracy of this HPLC procedure was evaluated on the recovery of known
amounts of compound. Accuracy is based on the closeness of the result obtained to the
true concentration. The compounds were injected three times at four different
concencentration levels (0.005, 0.05, 0.5, and 5µM). The results from accuracy studies
for resveratrol and pterostilbene are shown in Table 2.3. The highest concentration
(5µM) for both compounds had the lowest RSD values.
For resveratrol, the recovery range was from 96.59% to 109.01% with RSD less
than 2.05%. The lower concentrations (0.005 and 0.05µM) had similar recovery
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pecentage. The highest concentration (5µM) had highest percentage of recovery of
109.01%. The recovery range for pterostilbene was between 99.53% to 106.29% with
the RSD less than 2.35%. The lowest concentration (0.005µM) had highest percentage of
recovery 0f 106.29%.

Table 2.3 Accuracy/Recovery data of resveratrol and pterostilbene standards.
% RSD
Compound
Concentration(µM)
% Recovery
(n=3)
Reservatrol
0.005
96.59
2.05

Pterostilbene

0.05

96.23

0.82

0.5

104.80

0.40

5

109.01

0.04

0.005

106.29

1.00

0.05

101.88

2.35

0.5

99.53

1.31

5

100.93

0.21

2.4.6 Precision
The precision for this study was determined based on repeatability (intraday
variation) and intermediate precision (interday variation) (ICH, 2005). Intraday variation
was evaluated by analyzing four different concentration levels (0.005, 0.05, 0.5, and
5µM) with triplicate injection within the same day; whereas, interday variation was
analyzing four different concentration levels (0.005, 0.05, 0.5, and 5µM) on three
separate days under the same experimental conditions.
For the intraday variation, resveratrol RSD values for retention time were between
0.00 - 0.23% and the RSD values for peak area were between 0.04% to 1.91%. The RSD
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values for retention time ranged from 0.04 to 0.49% and the RSD values for peak area
were between 0.21% to 2.46% for pterostilbene. (See Table 2.4)
For interday variation of resveratrol, the percent RSD of the retention time and
peak were between 1.70% to 2.70% and 0.39% to 7.60%, respectively. For pterostilbene,
RSD values for retention time were between 1.86% to 3.36% and the RSD values for
peak area were in the range of 4.20 to 8.54%.

Table 2.4 Precision data of resveratrol and pterostilbene standards.
Intraday variation
Compound

(%RSD)(n=3)

Concentration
(µM)

Retention
time

Reservatrol

Pterostilbene

Interday variation

Peak area

(%RSD)(n=3)
Retention
time

Peak area

0.005

0.23

1.91

1.83

4.29

0.05

0.23

0.76

2.02

0.39

0.5

0.13

0.40

2.70

7.37

5

0.00

0.04

1.70

7.60

0.005

0.28

1.34

2.15

8.54

0.05

0.49

2.45

2.19

4.31

0.5

0.16

1.35

3.46

4.20

5

0.04

0.21

1.86

7.83

2.4.7 Analysis of resveratrol and pterostilbene in commercial juice products
The amount of resveratrol and pterostilbene present in the six different brands of
juices were determined by the HPLC method developed for this paper. The results listed
in Table 2.5. All the samples that contained blueberries juice (Blueberry Juice 1 and 2;
Mix Juice Blend 1 and 2) had pterostilbene present. Blueberry Juice 1 had the highest
concentration of reveratrol and pterostilbene. Blueberry Juice 1 contained organic
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blueberry juice concentrate. Resveratrol can naturally be found in great abundance in
grapes and there is a significant amount also found in blueberries. In nature, there is
more pterostilbene found in blueberries than in grapes, which would explain why there is
little, if any, pterostilbene found in the grape juices samples (Rimando et a.l, 2004).
Table 2.5 Amount of resveratrol and pterostilbene in different juice products.
Juice Sample
Resveratrol (µM)
Pterostilbene(µM)
Grape Juice 1

0.451

Trace Amount

Grape Juice 2

1.988

None

Blueberry Juice 1

6.584

0.021

Blueberry Juice 2

1.963

0.016

Mix Juice Blend 1

2.205

0.005

Mix Juice Blend 2

0.950

0.002

2.5 Conclusion
In conclusion, this method developed, by using HPLC coupled with an EC
detector for the determination of resveratrol and pterostilbene, was simple, rapid and
highly sensitive. Linear, range, repeatability and intermediate precision, LOD, LOQ and
recovery were used to successfully validate this analytical method.
When this method is compared to HPLC methods using other detectors for the
detection of resveratrol and pterostilbene, like UV and fluorescence, this method was
faster and provides greater sensitivity (Buiarelli an et al., 2006; Gocan, 2009; Lui et al.,
2009; Rodríguez-Bernaldo de Quirós et al., 2007; Remsberg, 2007). In our lab, this
method has been used to analyze small amounts of resveratrol and pterostilbene for
permeability and cellular uptake experiments as well as determine the concentration of
resveratrol and pterostilbene in various food products. The application of this method
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will allow for analyzing large quantities of samples in a relatively short period of time, in
addition to be able to detect trace amounts of resveratrol and pterostilbene for future
nutritional, toxicological, and pharmacological research.
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CHAPTER 3
COMPARISON OF THE CELLULAR UPTAKE AND INHIBITORY EFFECTS
OF RESVERATROL AND ITS METHYLATED ANALOGUE PTEROSTILBENE
ON HUMAN COLON CANCER CELLS

3.1 Abstract
Colon cancer is the third most commonly diagnosed cancer. Numerous
epidemiological studies have revealed a relation between high consumption of fruits and
vegetables with reduced risk of colon cancer. Resveratrol and pterostilbene are stilbene
compounds found in fruits such as grapes and blueberries. The aim of this study was to
compare the cellular uptake and inhibitory effects of resveratrol and pterostilbene on
human colon cancer cells. Pterostilbene had a stronger inhibitory effect than resveratrol
on Caco-2 human colon cancer cell line. Pterostilbene IC50 value was approximately 2.5
times lower than resveratrol. The cellular uptake of reseveratrol and pterostilbene in
three human colon cancer cells (Caco-2, HT-29, and HCT-116) was examined. The
cellular uptake of pterostilbene was around 2 to 3 fold higher than of resveratrol in all
colon cancer cells. The increased intracellular uptake and stronger growth inhibitory by
pterostilbene maybe contributed to the two methyl groups on pterostilbene. Pterostilbene
is an appealing candidate for cancer prevention.

Keywords: Resveratrol; Pterostilbene; Uptake; Colon Cancer; MTT
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3.2 Introduction
In 2012, the World Health Organization (WHO) projected that cancer will be the
most prevailing cause for death worldwide surpassing heart disease and stroke.
According to the American Cancer Society (2012), cancer is the second most common
cause of death in the United States and accounts for about one in every fourth deaths.
The third most commonly diagnosed cancer in the United States is colon cancer and there
has been noticeable increase in incidents in adults under the age of 50 (Siegel, 2009).
These staggering statistics has triggered a surge of interest in cancer prevention.
Diet and lifestyle has received much attention since they are effective means of
prevention. They are both major contributing factors as to whether or not one develops
cancer (Center et al, 2009; McCullough et al, 2011). Having a diet abundant in fruit and
vegetables is essential in maintaining good health. Numerous epidemiological studies
have revealed a relation between high consumption of fruits and vegetables associated
with a reduced risk of colon cancer (Rimando and Suh, 2008; Van Duijnhoven et al.,
2009).
Reservetrol has been shown to exert anti-carcinogenic properties (Athar et al.,
2009). In vitro models, Aggarwal et al. (2000) and Juan et al. (2008) have demonstrated
reservatrol ability to be anti-angiogenic, anti-porliferative and proapototic. Furthermore,
resveratrol has been shown to inhibit tumor progression in multiple sites such as breast,
gastrointestinal tract and skin (Bishayee, 2009). In spite of all its potent as anti-cancer
agent (Gupta et al., 2011; Li et al., 2010), the bioavailability of resveratrol has been a
concern due to its rapidly metabolizing leaving small amounts of unconjugated
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resveratrol in the systemic circulation (Asensi et al., 2002 Kapetanovic et al, 2010). This
has spark researcher is explore resveratrol derivatives.
Pterostilbene (trans-3,5-dimethoxy-4’-hydroxystilbene), a dimethylether analogue
of resveratrol, has been shown to exhibit strong inhibitory activity again difference
cancer cell lines (Billack et al., 2008; Huang et al., 2007; Paul et al, 2010) and overall
better pharmacokinetic characteristics than resveratrol (Lin et al., 2009; Remsberg et al.,
2007; Wilson et al., 2008). In vivo study, pterostilbene had a longer plasma half-life in
comparison to resveratrol (Ferrer et al., 2005), which is why pterostilbene is an
interesting compound to investigate as a potential compound for use in chemoprevention.
The objective of this study is to see if the structural differences between
resveratrol and pterostilbene would affect their inhibitory effects in Caco-2 - colon cancer
cell line as well as compare the cellular uptake of the two compounds in three human
colon adenocarcinoma cell lines.

3.3 Materials and Methods

3.3.1 Materials
Highly purified trans-resveratrol (99%) and pterostilbene(98%) were obtained
from Quality Phyochemical LLC (NJ, USA). All organic solvents utilized were of HPLC
grade and purchased from Fisher Scientific (Fairlawn, NJ, USA). Ammonium Acetate
(99%) was purchased from EMD Chemicals Inc. (Gibbstwon, NJ, USA). All three human
colon adenocarcinoma cell lines were obtained from American Type Cell Collection
(Manassas, VA, USA). Penicillin and streptomycin were obtained from Sigma-Aldrich
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(St. Louis, MO, USA). Dulbecco’s modified eagle medium (DMEM), McCoy’s 5A
media, fetal bovine serum (FBS), MEM non-essential amino acid, HEPES and other cell
culture supplies were purchased from Mediatech Inc. (Herndon, VA, USA).

3.3.2 Cell culture treatment
Caco-2 cells were maintained in DMEM containing glucose, L-glutamine, and
sodium pyruvate, supplemented with 10% fetal bovine serum, 0.1% MEM non-essential
amino acid, 6mM HEPES, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. HCT116
and HT-29 were maintained in McCoy’s 5A media supplemented with 5% heat
inactivated FBS, 100 U/mL of penicillin, and 0.1mg/mL streptomycin.
All cell lines were kept at 37°C in atmosphere of 5% CO2 and 95% air. Cells
were subcultured at 70-90% confluency with media changed every 2 to 3 days for Caco-2
cells and every other day for HCT116 and HT29. Cell lines used were between 15 and
30 passages. DMSO was utilized as the agent to deliver resveratrol and pterostilbene.
The final concentration of DMSO in all experiments did not exceed 0.1%.

3.3.3 Cell Viability Assay
Caco-2 cells were seeded in 96-well plates at a density of 10,000 cells/well. After
24 hours of incubation, media was replaced and cells were treated with serial
concentrations of resveratrol and/or pterostilbene in 200µl in complete serum media
except for the control samples that contained media with only 0.1% DMSO. At the end
of treatment period of 48 hours, cells were subject to 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) assay; therefore, the media was replaced with 100µl
of fresh complete media containing 0.5mg/ml of MTT (Sigma-Aldrich, St. Louis, MO,
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USA). After 2 hours of incubation at 37˚C, the media containing MTT was removed and
the reduced formazan dye was solubized by the addition of 100µl of DMSO per well.
After lightly tipping the plate to dissolve the DMSO, the absorbance was evaluated at
570nm using a spectrophotemtric microtiter plate reader (Elx800TM absorbance
microplate reader, BioTek Instrument, Winooski, VT, USA). Results were expressed as
percentage of viable with 100% representing the control cells treated with only DMSO.

3.3.4 Cellular Uptake Assay
The colon cancer cells (400 cells/ml) were suspended in 1ml of culture media
containing different concentrations of resveratrol and/or pterostilbene in glass tube and
then were incubated at 37°C in atmosphere of 5% CO2 and 95% air for 0.5, 1, or 2 hours.
After incubation, the cell suspension wase centrifuged at 2000 rpm for 2 minutes at 4°C.
Supernatant was then removed and cells were rinsed with 1ml of ice-cold PBS (1X; pH
7.25) and centrifuged at 1000 rpm for 1 minute at 4°C. After centrifugation, supernatant
was again removed and 1ml of cytosol buffer (pH 7.5, 10mM-Tris-HCL, 1mM EDTA,
1mM MgCl2) was added. The solution was kept on ice for 5 minutes before cells were
sonicated with a probe sonicator and transferred to eppendorf tubes. The cells were then
centrifuged at 14,000rpm for 25 minutes at 4°C. The supernatant was used to determined
protein amount by BCA assay (Foster et al., 2001).

3.3.4.1 Cytosol Faction
After centrifugation, the supernatant was transferred to a new tube. 180µl of
supernatant was added to 120µl of MeOH (40% MeOH concentration). The 300µl of
ethyl acetated (equal volume to the supernatant/MeOH solution) was added to
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suspernatant/MeOH and centrifuged at 10,000 rpm for 5 minutes at 4°C. The ethyl
acetate layer (top layer) was collected. Ethyl acetate was added again to the
supernantant-MeOH solution and centrifugated at 10,000rpm for 5 minutes at 4°C. Then
ethyl acetate was collected again. The collected ethyl acetate extracts were evaporated to
dryness and reconstitued in 180µl of 50% MeOH and analyzed using HPLC-EC. The
peak areas were compared to standards and the cellular uptake was normalized for
cellular protein.

3.3.4.2 Membrane Fraction
The membrane buffer (pH 6.5, 25mM HEPES, 150mM NaCl, 10% Triton, 60mM
OCG) was added to the cell pellet. After 30 minutes on ice, 80µl of MeOH was added
and solution was votexed. 200µl of ethyl acetate was added to membrane-MeOH
solution. The solution was centrifuged at 10,000rpm for 5 minutes at 4°C. The ethyl
acetate (top layer) was collected. Ethyle acetate was added again to the membraneMeOH solution and centrifugated at 10,000rpm for 5 minutes 4°C. Then ethyl acetate
was collected. The collected ethyl acetate were evaporated to dryness and reconstitued in
120µl of 50% MeOH and analyzed by HPLC-EC. The peak areas were compared to
standards.

3.3.5 HPLC analysis
Samples were analyses on CoulArray® HPLC system, obtained from ESA
(Chelmsford, MA, USA), equipped with a binary solvent delivery system (model 584),
an auto-sampler (model 542), a CoulArray® Multi-Channel EC detector (model 6210)
consisted of two cells, each cell contains 4 channels, and a UV detector. Ascentis RP39

Amide column (15 cm x 4.6 mm id, 3 µm) from Sigma-Aldrich (St. Louis, MO, USA)
was used. Data collection, processing and instrument control were achieved using the
CoulArray 3.06 software.
The mobile phase used consisted of 50mM ammonium acetate in 50% water, 40%
ACN, and 10% THF. The pH of the mobile phase was adjusted with TFA to achieve a
pH range between 3.5 to 3.8 and then filtered through a 0.45µm membrane filter from
Millipore (Bedford, MA, USA). Both EC detector cells were used and detection
potentials were set to 300, 400, 500, 600, 700, 800 and 900 mV. The flow rate was set to
1.0 ml/min. The temperature of the auto-sampler was set to 4°C. This detection method
has high selectivity and excellent sensitivity even at low concentrations.

3.3.6 Statistical Analysis
Data were expressed as mean ± standard error mean (SEM). Statistical
significance of mean difference between two groups was calculated by using Student’s
two-tailed t-test. Analysis of variance (ANOVA) model with Dunnett multiple
comparison was used when comparing more than two groups’ differences. A
significance level of P <0.05 was used for all tests.
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3.4 Results & Discussion

3.4.1 Growth inhibition on Caco-2
The colorimetric assay MTT was utilized to determine cell viability; therefore,
determining the growth inhibition effect of resveratrol and pterostilbene on Caco-2 colon
cancer cells. The cell viability is directly proportional to the intensity of the color in the
solution in each well (Mosmann, 1983). The results showed that both resveratrol and
pterostilbene caused dose-dependent growth inhibition of the cell viability of Caco-2
colon cancer cells (Figure 3.1). Resveratrol IC50 value was estimated to be around
207μM while pterostilbene attained a significantly lower IC50 value of approximately
79μM. Pterostilbene was around 2.6 times more potent than resveratrol in hindering
growth.
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Figure 3.1 Growth inhibitory effect of resveratrol and pterostilbene on CaCo-2
human colon adenocarcinoma cells. Cells were seeded on 96-well plates for 24 hours.
After this period of time, cells were treated with serial concentrations of resveratrol or
pterostilbene. After 48 hours of treatment, growth inhibition was measured by MTT assay
as described in material and method section. Each point represents the mean ± SEM.
(n=6).

3.4.2 Cellular Uptake of 3 Colon Cancer Cell Lines
The cellular uptake of resveratrol and pterostilbene in three different human colon
cell lines, Caco-2, HT-29 and HCT-116 were evaulated. The results revealed that in all
cell lines the cellular uptake of pterostilbene in the cytostol was statistical significantly
higher than resveratrol (Figures 3.2A, B and C). Similar results were obtained when the
membrane fraction of the cellular uptake of the colon cell lines were examined (Results

42

not shown). Also, there were no synergistic or inhibitor effects observed when cells were
exposed to both compounds at the same time.
After 0.5 hours of exposure, all cells lines were statistically different from each
other in the presences of either compound (Figures 3.2D and E). There was no difference
between HT-29 and HCT-116 cellular uptake of resveratrol or pterostilbene at the 1 hour
and 2 hour incubation periods. Caco-2 had the most cellular uptake of resveratrol for all
treatment times in comparison to HT-29 and HCT-116. However, when cells were
exposed to pterostilbene, HT-29 had the most cellular uptake at 0.5 hours but then uptake
amounts reduce to that similar to HCT-116 for other treatment times (1 and 2 hour).
In examining the overall cellular uptake ratio of pterostilbene to resveratrol in the
different colon cell lines, HCT-116 and Caco-2 had similar ratios (Figures 3.3A, B, and
C). HT-29 exhibits a considerably higher ratio of cellular uptake of pterostilbene to
resveratrol at 0.5 hours compared to the two other cell lines by approximately four folds.
However, HT-29 uptake levels off to similar ratios as the 1 hour and 2 hour time pulls as
the other cell lines. The cellular uptake treatments clearly illustrated that pterostilbene
was taken up into the cell more readily than resveratrol.
Since a cell suspension was used to determine cellular uptake, resveratrol and
pterostilbene had more accessibility to the cells than conventional uptake methods, where
cells are grown to confluence in plastic plates that merely allow apical membrane access.
Also, this method alleviates any difficulties that may occur from scraping cells from the
plastic plates; therefore, decreasing the variation after sample collection. (Henry et al.
2005; Sacclui et al., 2002; Vaidyanathan and Walle, 2003).
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Figure 3.2 Cellular uptake of resveratrol and pterostilbene in the cytosol of (a)Caco-2,
(b)HT-29, and (c)HCT-116 human colon cancer cell lines. Colon cancer cells were
incubated with 10μM of (d) resveratrol or (e) pterostilbene in complete medium for
various time periods. Each point represents the mean (n=3) ± SEM. * indicates a
statistical significance between resveratrol and pterostilbene in the same cell line at the
same incubation period. ** indicates a statistical significance between all cell lines at the
same incubation period. *** indicates only a statistical significance between Caco-2 and
other cells lines (HT-29 and HCT-116) but not between each other (HT-29 and HCT116) at the same incubation period.
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Figure 3.3 Cellular uptake ratio of pterostilbene to resveratrol in the cytosol of
Caco-2, HT-29, and HCT-116 human colon cell lines. The cells were incubated with
10μM resveratrol or pterostilbene in complete medium for (a) 0.5, (b) 1, and (c) 2 hours.
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3.5 Conclusion

The present study is part of our labs current investigation on accessing the
bioavailability and potential health benefits of methalyed flavones. In this study, there
was an examination of the effects of resveratrol and pterostilbene on three different
human colon cancer cell lines – Caco-2, HT-29, and HCT-116. Both resveratrol and
pterostilbene are naturally occurring stilbene that have the same core structure but differ
by their functional groups. Pterostilbene has methoxy groups on the 3 and 5 position on
the phenyl ring A instead of the hydroxyl groups that resveratrol contains at these
positions.
MTT viability assay was used to determine the growth inhibition of the
resveratrol and pterostilbene. The assay revealed that pterostilbene had a stronger
inhibitory effect than resveratrol on Caco-2. Pterostilbene IC50 value was approximately
more than 2.5 times lower than that of resveratrol. In our lab has also explored the
inhibitor effects of resveratrol and pterostilbene on other human colon cancer lines
(HCT116 and HT-29) and similar results were observed (Nutakul et al., 2011).
These findings are in agreement with prior reports that showed the methoxlyated
derivative have higher bioactivity and increased totoxic activity (Huang et al., 2007;
Wilson et al., 2008). Previous studies have shown that the structural difference of the
stilbene compounds contribute to difference in their activities (Jospeh et al. 2008; Ovesna
and Horvathova-Kozics, 2005; Stivala et al., 2001). Other methylated flavones have
shown to have more potent inhibition of growth versus unmethylated counterparts as well
(Walle et al., 2007).
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Bioavailability is key factor that can influence the efficacy of bioactive of a
compound. Only bioavailable compounds can be accessible to the target cells to be
bioactive for these cells. The results obtain suggest greater potency of pterostilbene than
resveratrol could potential be because of greater cellular uptake of the pterostilbene.
Therefore, we investigated cellular uptake of resveratrol and pterostilbene in three human
colon cancer cell lines – Caco-2, HT-29, and HCT-116.
The cellular uptake experiments demonstrated a significant higher uptake of the
pterostilbene than resveratrol in all cell lines. The substitution of hydroxy with methoxy
group makes pterostilbene more lipophilic than resveratrol (Cichocki, 2008;Paul et al,.
2009), therefore, pterostilbene may be able to permeate the plasma membrane of the cell
and in turn enter the cytsol of the cell more readily than that of reservatrol (Tolomeo et
al., 2005). As a consequence of better cellular uptake, the higher intracellular levels of
pterostilbene can cause more potent inhibitory effects on the colon cancer cells in
comparison to resveratrol. There may also be the probability that each colon cancer cell
have different preference in taking up pterostilbene and resveratrol.
In conclusion, on the basis of the above findings, pterostilbene has stronger anticarcinogenic effect and better bioavailabilty in comparison to resveratrol in human colon
cancer cells. This study highlights that pterostilbene merits additional investigation as a
chemopreventive agent in humans against colon cancer.
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CHAPTER 4
COMPARISON OF PERMEABILITY AND TRANSPORT OF RESVERATROL
AND ITS METHYLATED ANALOGUE PTEROSTILBENE IN HUMAN
INTESTINAL CACO-2 CELLS

4.1 Abstract
Resveratrol and pterostilbene are both structurally related stilbene compounds that
have been shown to possess a wide range of therapeutic benefits. Caco-2 cells
monolayers were utilized to evaluate the transport of resveratrol and/or pterostilbene
from apical to the basolateral compartment and from the basolateral to apical
compartment. Samples were analyzed using high-performance liquid chromatography
equipped with electrochemical (HPLC-EC). Resveratrol exhibited a higher rapid rate of
transport than pterostilbene across the Caco-2 monolayer regardless of the concentration
tested and direction. The transport of resveratrol was linear for only an hour; whereas,
the transport of pterostilbene stability increased for the first 3 hours and did not reach a
plateau until 6 hours into examination. There was little difference in the rate of transport
of pterostilbene in either direction. Pterostilbene had an extended period of linear
transport than resveratrol, suggesting less extensive pre-systemic metabolism than
reservatrol which may lead to greater bioavailability and biological activity than
resveratrol. Further research is warranted to investigate how these closely related
structures can be utilized effectively for cancer prevention.

Keywords: Resveratrol; Pterostilbene; Stilbene; Caco-2; Permability; Transport
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4.2 Introduction
Resveratrol and pterostilbene are both naturally derived polyphenol compounds
belonging to the stilbene family. It has long been postulated that resveratrol, which is
present in wine, maybe the reason for the “French Paradox”. This epidemiological
phenomenon is that the French population has a drastically lower incidence of
cardiovascular disease despite having a diet higher in fat than other populations
(Vidavalur et al., 2006). Resveratrol has been show to block human platelet aggregation,
which may lower ones chance of developing cardiovascular disease (Bertelli et al., 1995;
Pace-Asciak et al., 1995). Pterostilbene exhibit similar properties as resveratrol as well
as its own distinctive therapeutic benefits (Rimando, 2002).
It is not clearly understood how resveratrol and even a greater extent pterostilbene
obtain access to an intended cellular site of action. Furthermore, little is known about
their absorption and bioavailability in humans. Various studies have demonstrated that
resveratrol is well absorbed in vitro; yet, in vivo, it has very low bioavailability (Goldberg
et al., 2003; Walle et al., 2004). Pterostilbene appears to have greater biological activity
based on having relatively higher bioavailiability than resveratrol in vivo (rats) (Lin et al.,
2009; Remerg et al., 2008).
For any compound of interest, their overall absorpiton, distribution, metabolism,
excretion and toxicity are crucial in evaulating a compounds prospective as a therapeutic
agent (Balani, 2005; Tetko et al., 2006). Since oral administration is a widely employed
method for the delivery of drugs and foods, the effectiveness of a compound is dependent
on their intestinal absorption to get into systemic circulation to subsequently reach the
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intented tissue. The intestinal epithelium is a key determinant for the oral absorption of
ingested pharmaceuticals, food ingredients and toxins (Tong and Wen, 2008).
The usage of Caco-2 monolayer to predict the intestinal absorption of compounds
is routinely utilized (Lind et al., 2007). Artursson and Karlson (1991) demonstrated a
good correlation between the rate of transport across Caco-2 cell monolayer to the
amount absorbed in humans by oral administration of a compound. These cells maintain
several of the functional and morphological characteristics of the in vivo intestinal
epithelial cells; therefore, Caco-2 cell monolayer is a vital model for in vitro absorption
screening (Fossati et al., 2008).
The intent of this study was to compare the permeability and transport of
resveratrol and its methylated analogue, pterostilbene, in Caco-2 cell model that were
cultured as monolayers on transwells. Samples were analyzed using high-performance
liquid chromatography equipped with electrochemical (HPLC-EC).

4.3 Materials and Methods

4.3.1 Materials
Highly purified trans-resveratrol (99%) and pterostilbene (98%) were obtained
from Quality Phyochemical LLC (NJ, USA). All organic solvents utilized were of HPLC
grade and purchased from Fisher Scientific (Fairlawn, NJ, USA). Ammonium Acetate
(99%) was purchased from EMD Chemicals Inc. (Gibbstwon, NJ, USA). The human
colon adenocarcinoma cell line, Caco-2, was obtained from American Type Cell
Collection (ATCC, Manassas, VA, USA). Polyester (PET) transwell inserts with a pore
size of 0.4µm and growth area of 4.67 cm2 were purchased from Corning Costar
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Corporation (New York, USA). Penicillin and streptomycin were obtained from SigmaAldrich (St. Louis, MO). Dulbecco’s modified eagle medium (DMEM), fetal bovine
serum (FBS), MEM non-essential amino acid, HEPES and other cell culture supplies
were purchased from Mediatech Inc. (Herndon, VA, USA).

4.3.2 Cell Culture - Caco-2
Caco-2 were cultured in DMEM containing glucose, L-glutamine and sodium
pyruvate, supplemented with 10% FBS, 0.1% MEM non-essential amino acid, 10mM
HEPES, 100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37°C in an atmosphere of
5% CO2 and 95% air. The cells were split when 70-90% confluent, using trypsin/EDTA,
and media was changed every 2 to 3 days.
Caco-2 cells utilized were between 15 and 40 passages. The culture medium was
changed three times a week after seeding and experiments were performed after 21 - 27
days of post-seeding. The final concentration of DMSO in all experiments did not
exceed 0.1%.

4.3.3 Transport Experiments
The transwell inserts was seeded with 2.5 X 105 cells/ml of Caco-2 cells. The
culture medium was changed three times a week after seeding and experiments were
performed after 21 to 27 days post seeding. Culture medium was changed 12 to 24 hours
prior to performing experiments. The culture medium was removed from both chambers
and the cells were washed twice for 30 minutes with pre-incubated (37°C) Hank’s
balanced salt solution (HBSS). The pH of HBSS in apical compartment was 6.5 and 7.4
for basolateral compartment.
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Samples from both compartments were withdrawn at specific times and the
volume take from each compartment was replenished to the initial volume with the
appropriate HBSS. Each sample was analyzed by HPLC-EC.

4.3.4 HPLC analysis
Samples were analyses on CoulArray® HPLC system, obtained from ESA
(Chelmsford, MA, USA), equipped with a binary solvent delivery system (model 584),
an auto-sampler (model 542), a CoulArray® Multi-Channel EC detector (model 6210)
consisted of two cells, each cell contains 4 channels, and a UV detector. Ascentis RPAmide column (15 cm x 4.6 mm id, 3 µm) from Sigma-Aldrich (St. Louis, MO, USA)
was used. Data collection, processing and instrument control were achieved using the
CoulArray 3.06 software.
The mobile phase used consisted 50% water, 40% ACN, 10% THF and 50mM
ammonium acetate The pH of the mobile phase was adjusted with TFA to achieve a pH
range between 3.5 to 3.8 and then filtered through a 0.45µm membrane filter from
Millipore (Bedford, MA, USA). Both EC detector cells were used and detection
potentials were set to 300, 400, 500, 600, 700, 800 and 900 mV. The flow rate was set to
1.0 ml/min. The temperature of the auto-sampler was set to 4°C.
This detection method has high selectivity and excellent sensitivity even at low
concentration. The range of validation (0.001 - 5µM) was linear with coefficients of
correlation more than 0.999 (Dong et al., 2010). Samples were stored at -20º C until
analysis.
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4.3.5 Data Analysis
Apparent permeability coefficient, Papp, (cm/s) of a compound was calculated by
using the equation below (Hubatch et al., 2007).

dQ/dt is steady-state appearance rate of compound in receiver compartment (µmol/s)
A is the surface area of the filter (4.67 cm2)
C0 is the initial concentration in the donor compartment (µM)

∑

[ ( )
[ (
)

(

)]
( )]

The cumulative fraction transported, FAcum, (cm) for each experiment was also
evaluated. See the equation above. This equation takes into account the weighted
normalized cumulative amount of a compound transported, where the amount of
transported compound in each time pulls is weighted by the inverse average driving force
(donor concentration for that time pull) (Hubatch et al., 2007).
Data were expressed as mean ± standard error mean (SEM). Statistical
significance of mean difference between two groups was calculated by using Student’s
two-tailed t-test. Analysis of variance (ANOVA) model with Dunnett multiple
comparison was used when comparing more than two groups’ differences. A
significance level of P <0.05 was used for all tests.

55

4.4 Results and Discussion

4.4.1 Overall
Caco-2 cell monolayers were utilized to evaluate the transport rate of resveratrol
and/or pterostilbene from apical to the basolateral compartment and from the basolateral
to apical compartment. The transport of the resveratrol and pterostilbene were monitored
over an 8 hour time period at three different concentrations (10, 25 and 50µM). Samples
from both compartments were taken at each time pull and replaced with buffer. Samples
were subsequently analyzed by HPLC-EC without any further preparation.
The concentration range we employed some claim is slightly lower than the range
of a compound in the gastrointestinal lumen following oral dose (Kerns and Di, 2008)
while others say slightly higher than expected in the gastrointestinal lumen after drinking
a cup of juice or glass of red wine (Fremont, 2000; Gescher, 2008). To better mimic
what occurs in the body after oral administration of a compound, a pH gradient was used,
where an acidic pH of 6.5 was utilized in the apical compartment and a neutral pH of 7.4
was utilized in the basolateral compartment (Lind et al. 2007). The acidic microclimate
models the pH of the upper small intestine under fasted conditions and the neutral pH
(7.4) in the basolateral side mimics the pH of the blood (Fallingborg et al., 1989;
Deferme et al., 2008).
When either resveratrol or pterostilbene were loaded on the apical or basolateral
compartment, they both were detected on the opposite side at the first time pull of 30
minutes and throughout the 8 hours incubation period. Both compounds at all three
concentrations evaluated, clearly demonstrated transcellular absorption (Figurres 4.3 and

56

4.4). When both resveratrol and pterostilbene were added to the apical compartment at
the same time together (data not shown), there was no synergistic effected occurred.
Table 4.1 summarizes the Papp for the first hour of transport for resveratrol and
pterostilbene. There was a distinctive difference between rates that resveratrol and
pterostilbene had across the Caco-2 monolayer and how concentration and direction
effect transports of these compounds.
The efflux ratio (Papp of baterolateral compartment to apical compartment / Papp of
apical compartment to basolateral compartment) for resveratrol and pterostilbene were
both less than 3 indicating that no efflux is occurring.
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Figure 4.1 The transport from the apical to the basolateral compartment of (a)
resveratrol and (b) pterostilbene across the Caco-2 monolayer. Each point represents the
mean (n=4) ± SEM.
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Figure 4.2 The transport from the basolateral to the apical compartment of (a)
resveratrol and (b) pterostilbene across the Caco-2 monolayer. Each point represents the
mean (n=4) ± SEM.
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Figure 4.3 Cumulative fraction transport from the apical to the basolateral compartment
of (a) resveratrol and (b)pterostilbene across the Caco-2 monolayer. Each point
represents the mean (n=4) ± SEM.
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Figure 4.4 Cumulative fraction transport from the basolateral to the apical compartment
of (a) resveratrol and (b) pterostilbene across the Caco-2 monolayer. Each point
represents the mean (n=4) ± SEM.
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Table 4.1 Apparent permeability coefficients or different concentrations of resveratrol
and pterostilbene through Caco-2 monolayers
Transport Direction
Compound
Concentration (µM)
Pappa: Apical to Basolateral Papp:a Basolateral to Apical

Resveratrol

Pterostilbene

a.

10

4.4±0.9

2.8±0.8

25

10.2±0.2

4.5±0.7

50

12.1±0.6

6.9±0.7

10

2.6±0.3

3.0±0.2

25

3.5±05

2.5±0.3

50

4.5±1.5

3.0±0.2

Papp is expressed in cm/sec (x 10-6). Values are means ± SEM. n=4.

4.4.2 Resveratrol
For the first hour of transport of resveratrol across the Caco-2 monolayers, there
was a linear increase in the amount of resveratrol transported when added to either
compartment (Figures 4.3A and 4.4A). However after 3 hours of inhibition, there was
plateau in transport of resveratrol, regardless of what compartment resveratrol was loaded
into. Also, there were slightly lower amount of resveratrol transported when resveratrol
was added on the basolateral compartment.
Transcellular absorption from the apical to basolateral compartment was observed
at all concentrations and appears to be concentration dependent (Figure 4.5A). As the
concentration of resveratrol increase from 10µM to 50 µM, the transport rate from the
apical to basolateral compartment more than doubled (Table 5.1).
The basolateral to apical flux of resveratrol was lower than transport from apical
to basolateral compartment (Figure 5.6A). Since there was limited linearity in transport
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of resveratrol with time, this could imply considerable metabolism of resveratrol by the
Caco-2 cells (Walle et al., 2007).

4.4.3 Pterostilbene
Transport of pterostilbene across the Caco-2 monolayer increased steadily for the
first three hours (Figure 4.3B and 4.4B). It took twice as long for pterostilbene to reach
plateau than resveratrol which was after 6 hours of incubation.
Pterostilbene, unlike resveratrol, did not exhibit concentration dependence when it
was added to basolateral compartment (Figure 4.6B). Transport was virtually identical
for each concentration and direction which demonstrates the absence of directiondependent transport (Figures 4.5B and 4.6B).
This suggests that the transport of pterostilbene across Caco-2 monolayers is
probably through a passive diffusion mechanism.

4.5 Conclusion
The objective of this study was to examine the transport of resveratrol and
pterostilbene across Caco-2 cell monolayer. Even though resveratrol and pterostilbene
have the same core structure; they differ in their functional groups. Resveratrol contain
3,5-dihydroxy motif on the phenyl A ring, while pterostilbene has 3,5-dimethoxy motif.
Resveratrol is the mostly studied stilbene; however, research on the absorptions of other
stilbene, especially ones with methylated groups, are still limited.
The usage of human intestinal cell line Caco-2 cultivated on permeable
membranes is a well accepted model of human intestinal absorption. It is critical to
understand the bioavailability of stilbenes in order to figure out their potential actions in
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vivo. Gres et al. (1998) determined that Papp values >2 × 10-6 cm/sec from Caco-2 cell
experiments ought to correlate with efficient intestinal absorption. As a result, it is
predicted that both resveratrol and pterostilbene can be effectively absorbed in humans.
Other stilbene have reported to have lower transport rates than both resveratrol and
pterostilbene (Kim et al., 2008)
Resveratrol exhibited a higher and more rapid rate of transport than pterostilbene
across the Caco-2 monolayer regardless of the concentration tested (10, 25 and 50µM)
and direction. The transport of resveratrol was linear for only one hour; whereas,
pterostilbene transport stability increased for the first 3 hours and did not reach a plateau
until 6 hours into examination. Regardless of what compartment pterostilbene was put
into and concentration examined (10, 25, 50), there was little difference in the rate of
transport of pterostilbene.
Previous studies also observed a reduction in transport of resveratrol over time
from the apical to basolateral compartment, which was clearly concentration dependent
(Kadlas et al., 2003; Maier-Salamon et al., 2006; Li et al., 2003;). Human studies
demonstrated peak levels resveratrol were reached at 30 minutes and one hour times after
oral dosing and rapidly declined afterwards (Goldberg et al., 2003). Since transport of
resveratrol had limited linearity over time, this could possibly be linked with increased
amount of resveratrol being metabolized over time. This could indicate low oral
bioavailability, due to the fact this has been observed in other polyphenols (Walle et al.,
1999).
The transport of pterostilbene in this study clearly demonstrated passive diffusion
permeation. Pterostilbene has been reported to not metabolized as quickly and have
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longer plasma half-live than resveratrol (Ferrer et al., 2005). Lin et al. (2009)
demonstrated pterostilbene has better pharmacokinetic characteristics than resveratrol.
Pterostilbene may have higher bioavailability than resveratrol, since the substitution of
the hydroxyl with methoxy group increases metabolic stability of most compounds.
In conclusion, this data showed that even though resveratrol absorbed more
rapidly than pterostilbene in the Caco-2 cell model, both would be efficiently absorbed in
the human intestine. The data revealed that pterostilbene had extended period of linear
transport than resveratrol suggesting less extensive pre-systemic metabolism than
resveratrol which may lead to greater bioavailability and biological activity than
resveratrol. Further research is warranted to investigate how these closely related
structures can be utilized for different therapeutic uses.
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CHAPTER 5
COMPARISON OF THE CELLULAR UPTAKE, PERMEABILITY AND
TRANSPORT OF POLYMETHOXYFLAVONES (PMFS)

5.1 Abstract
Polymethoxyflavones (PMFs) naturally exist in citrus genus and accumulating
amount of evidence suggesting they have health-promoting benefits but there has been a
lack of research on examining their bioavailability. Samples were analyzed using highperformance liquid chromatography equipped with electrochemical (HPLC-EC). A cell
suspension in glass tubes were used to determine cellular uptake in HCT-116 human
colon cells. Caco-2 cells monolayers were used to evaluate the transport of PMFs from
apical to the basolateral compartment. The HCT-116 human colon cells had intracellular
uptake of each of the polymethoxyflavones (PMFs) tested. Transport was observed by all
the PMFs and each had different permeability rates. Overall, the results demonstrated that
location and amount of methyloxly groups have an effect on intracellular levels of the
PMF in HCT-116 and the rate of transport.

Keywords: Polymethoxyflavones, Permeability; Transport Caco-2 cells, Cancer,
Bioavailability
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5.2 Introduction
Polymethoxyflavones (PMFs) exist almost exclusively in the citrus fruits in
nature, particularly in the peel of sweet oranges and mandarin oranges (Li et al., 2006).
Currently, more than 20 PMFs have been isolated and identified. For centuries, orange
peels have been used in Asian culture to heal varies aliments (Ou, 1999). PMFs have
been well documented on their broad array of biological activities, such as antiatherogenic (Whitman et al., 2005), anti-carcinogenic (Ikeda et al., 2006; Manthey and
Najla, 2002) and anti-inflammatory (Li et al., 2006).
It is estimated that 2.2 million metric tons (MMT) of orange juice will be
produced worldwide this year (USDA: Foreign Agricultural Service, 2012) which will
yield a considerable amount of orange peel by-product. There are some PMFs in
commercial juices due to the industrial process being contaminated with peel constituents
(Gattuso et al., 2007) but most PMFs will come from the peel by-product of the orange
juice process which could potential be used for therapeutic purposes.
However, there is a scarce amount of research out on the bioavailability of PMFs.
For any compound, the overall effects of absorpiton, distribution, metabolism, and
excretion are vital in examining a compounds prospective as a therapeutic agent. The
term bioavailability is defined as the fraction of an ingested component that eventually
ends up in the blood systemic circulation system and target tissue (Van de Waterbeemd et
al., 2003).
Caco-2 cells model is widely used in vitro model to examining intestinal
transport, biotransformation and bioavailability at the cellular level. They have similar
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morphology as human intestinal epithelial cells such as forming polarized monolayers in
cultures and differentiate into cells (Fossati et al., 2008; Lind et al., 2007).
This study will focus on the following PMFs:


5-hydroxy-6,7,8,3’,4’-pentamethoxyflavone (PMF3)



5-hydroxy-3,6,7,8,3’,4’-hexamethoxyflavone (PMF4)



5-hydroxy-6,7,8,4’-tetramethoxyflavone (PMF7)

See Table 1.1 for chemical structure of these PMFs as well as other PMFs used in
this study. The object of this study was to investigate if cellular uptake of PMFs occurs
in HCT-116 colon cancer cells and to evaluate their transport in Caco-2 cell models.

5.3 Materials and Methods

5.3.1 Materials and Reagents
All organic solvents utilized, acetonitrile (ACN), methanol (MeOH),
tetrahydrofucan (THF) and trifluoroacetic acid (TFA), were of HPLC grade and
purchased from Fisher Scientific (Fairlawn, NJ, USA). Ammonium Acetate (99%) was
purchased from EMD Chemicals Inc. (Gibbstwon, NJ, USA). Penicillin and
streptomycin were obtained from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s
modified eagle medium (DMEM), McCoy’s 5A media, fetal bovine serum (FBS), MEM
non-essential amino acid, HEPES and other cell culture supplies were obtained from
Mediatech Inc. (Herndon, VA, USA). Polyester (PET) transwell inserts with a pore size
of 0.4µm and growth area of 4.67 cm2 were purchased from Corning Costar Corporation
(New York, USA).

68

Both human colon adenocarcinoma cell lines, Caco-2 and HCT116, were obtained
from American Type Cell Collection (ATCC, Manassas, VA, USA). PMFs were isolated
from sweet orange (Citrus sinensis) peel extract (cold pressed oil) and dissolved in
dimethyl sulfoxide (DMSO). They were identified by MS, UV and NMR (Li et al.,
2006). DMSO was used as the vehicle to deliver PMFs and the final concentration of
DMSO in all experiments was 0.1% in culture media.

5.3.2 Cell Culture Treatment
HCT-116 were maintained in McCoy’s 5A media supplemented with 5% heat
inactivated FBS, 100 units/mL of penicillin, and 0.1 mg/mL of streptomycin at 37ºC in an
atmosphere of 5% CO2 and 95% air. Cells were kept sub-confluent and culture media
were changed every other day. HCT-116 cells utilized were between 10 and 25 passages.
Caco-2 were cultured in DMEM containing glucose, L-glutamine and sodium
pyruvate, supplemented with 10% FBS, 0.1% MEM non-essential amino acid, 10mM
HEPES, 100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37°C in an atmosphere of
5% CO2 and 95% air. The cells were split when 70-90% confluent, using trypsin/EDTA,
and media was changed every 2 to 3 days. Caco-2 cells used were within 15 to 40
passages.

5.3.4 Cellular Uptake Assay
HCT-116 human colon adenocarcinoma cells (200 cells/ml) were suspended in
1ml of culture media containing different PMFs in glass culture tube and then incubated
at 37°C with atmosphere of 5% CO2 and 95% air for a given period of time (0.25, 0.5, 1
and 2 hours). After incubation, cell suspensions were centrifuged in a benchtop
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centrifuges at 12000rpm for 5 minutes. The supernatant was then removed and cells were
suspended with 1ml of ice-cold PBS (1x; pH7.25) and then sonicated. The cells
suspension was again centrifuged (12000rpm for 5 minute). From the supernatant
obtained, some was collected and reserved for the protein analysis by Bicinchoninic Acid
(BCA) assay (Wang et al., 2008).
Equal amount of supernatant and MeOH were sonicated and then centrifuge again
(12000rpm for 5 minutes). The supernatant obtained was collected for the HPLC
analysis to determine the amount of PMF in the cytosol faction.

5.3.5 Transport Experiments
The transwell inserts was seeded with 2.5 X 105 cells/ml of Caco-2 cells. The
culture medium was changed three times a week after seeding and experiments were
performed after 21 to 27 days post seeding. Culture medium was changed 12 to 24 hours
prior to performing experiments. The culture medium was removed from both chambers
and the cells were washed twice for 30 minutes with pre-incubated (37°C) Hank’s
balanced salt solution (HBSS). The pH of HBSS in apical compartment was 6.5 and 7.4
for basolateral compartment.
Samples from both compartments were withdrawn at specific times and the
volume take from each compartment was replenished to the initial volume with the
appropriate HBSS. Each sample was analyzed by HPLC-EC.

5.3.6 Sample Analysis
Samples were analyzed on CoulArray® HPLC system, obtained from ESA
(Chelmsford, MA, USA). It was equipped with a binary solvent delivery system (model
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584), an auto-sampler (model 542), a CoulArray® Multi-Channel EC detector (model
6210) consisted of two cells (each cell contains 4 channels) and a UV detector. Ascentis
RP-Amide column (15 cm x 4.6 mm id, 3 µm) from Sigma-Aldrich (St. Louis, MO,
USA) was used. Data collection, processing and instrument control were achieved using
the CoulArray 3.06 software.
The mobile phase used consisted of 50% water, 40% ACN, 10% THF and 50mM
ammonium acetate. The pH of the mobile phase was adjusted with TFA to achieve a pH
range between 3.5 to 3.8 and then filtered through a 0.45µm membrane filter from
Millipore (Bedford, MA, USA). Both EC detector cells were used and detection
potentials were set to 200, 300, 400, 500, 600, 700 and 800mV. The flow rate was set to
1.0 ml/min. The temperature of the auto-sampler was set to 4°C.
This detection method has high selectivity and excellent sensitivity even at low
concentration. The range of validation (0.001 - 5µM) was linear with coefficients of
correlation more than 0.999. Samples were stored at -20º C until analysis.

5.3.7 Data Analysis
Apparent permeability coefficient, Papp, (cm/s) of a compound was calculated by
using the equation below (Hubatch et al., 2007).

dQ/dt is steady-state appearance rate of compound in receiver compartment (µmol/s)
A is the surface area of the filter (4.67 cm2)
C0 is the initial concentration in the donor compartment (µM)
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The cumulative fraction transported, FAcum (cm), for each experiment was also
calculated. See the equation above. This equation takes into account the weighted
normalized cumulative amount of a compound transported, where the amount of
transported compound in each time pulls is weighted by the inverse average driving force
(donor concentration for that time pull) (Hubatch et al., 2007).
Data was expressed as mean ± standard error mean (SEM). Statistical
significance of mean difference between two groups was calculated by using Student’s
two-tailed t-test. Analysis of variance (ANOVA) model with Dunnett multiple
comparison was used when comparing more than two groups’ differences. A probability
of less than 0.05 (p < 0.05) was deemed statistically significant.

5.4 Results & Discussion

5.4.1 Cellular Uptake of PMFs in HCT-116 cancer cells
The ability of a compound to generate a biological effect depends on if it can first
enter the target cell. This study attempts to provide this insight by evaluating the
intracellular levels of PMFs in HCT-116 human colon adenocarcinoma cells. The results
were normalized with the amount of cytosolic protein (Foster et al., 2001). An array of
different cellular uptake experiments were performed. Individual PMFs were examined
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and then assessed to see if combined with other PMFs there would be an increase in
cellular uptake of the PMF of interest. Some experiments had HCT-116 cells exposed to
one PMF for 24 hours prior to treatment and then exposed to another PMF to determine if
later PMF would have greater intracellular uptake because cells were exposed to another
PMF prior.
Overall, there was no synergistic effect observed when an additional PMF was
added to the cellular uptake experiment to see if it would have an effect on the other PMF
(the one of interest). There was dose dependent observed; therefore, the intracellular
levels of PMF in the cell would increase with a increase in the amount of PMF exposed
to the cells (More PMF added the more was uptaken). When PMF4, PMF5 and PMF7
were compared to the uptake of PMF3 from PMF mixture (25uM of each), there was less
PMF4, PMF5 and PMF7 uptake in comparison to PMF3 (Figure 5.1). Slightly less
PMF7 was uptake in comparison to PMF 4 and PMF5.
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Figure 5.1 Percentage of cellular uptake in HCT-116 human colon cancer cells of
PMF4, 5 and 7 from the PMF mixture in comparison to uptake of PMF3 from the same
mixture. The values are mean ± SEM (n=3).
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5.4.2 Transport of PMFs by Caco-2 cells
A scarce number of studies exist on the transport of PMFs, in particular the PMFs
which were examined in this study. The ability of a compound to be effectively absorbed
in human intestine is a critical step in determining its bioavailability. Caco-2 cell
monolayers were utilized to evaluate the transport of PMFs from apical to the basolateral
compartment. The apical-to-basolateral transport of the PMF3, 4 and 7 were monitored
over an 8 hour time period using a concentration of 2.5µM. An assortment of other
transport experiments was also performed. A pH gradient was used to examine the
transport of PMFs because this better mimics what happens in the body after oral
administration of a compound (Lind et al. 2007). In the apical compartment, the acidic
microclimate (pH 6.5) mimics the pH of the upper small intestine under fasted conditions
and the neutral pH (7.4) in the basolateral side imitates the pH of the blood (Fallingborg
et al., 1989; Deferme et al., 2008).
When PMFs were individually loaded on to the apical compartment, PMF3 and
PMF4 were observed on the opposite compartment at 30 minutes and throughout the 8
hour experiment. However, PMF7 was not detected until 90 minutes into the transport
experiment at the same concentration as the other PMFs. Even when the concentration of
PMF7 was double to 5 µM, it was not detected on the opposite compartment until 30
minutes into the experiment. There was no significance increase or change overall in the
transport of the PMFs when all PMFs were added to the apical compartment in
comparison to when only individual PMFs were added to the apical compartment. Other
combinations with other compounds (PMF1, PMF2, Resveratrol and Pterostilbene) were
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evaluated to see if there would be significance change to transport of the PMF3, PMF4
and PMF7 but no such observation was detected.
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Figure 5.2 Cumulative fraction transported from the apical to the basolateral
compartment for PMF3, PMF4 and PMF7across the Caco-2 cell monolayer. Each point
represents the mean ± SEM. n=4.

Transcellular absorption clearly occurred for all the PMFs (Figure 5.2). PMF3
had the largest amount of transported to the basolateral compartment and largest apparent
permeability coefficient in comparison to PMF4 and PMF7 (Table 5.1). PMF7 had the
lowest amount of compound transfer across the Caco-2 monolayer. There was a
progressive increase in transport of both PMF3 and PMF4 for the first 5 hours of

76

transport yet PMF7 had a steady increase in transport throughout the transport
experiment.

Table 5.1 Apparent permeability coefficients of the PMFs through Caco-2cell
monolayers.
Compound
Pappa
PMF3

22.3±2.5

PMF4

7.4±0.8

PMF7

1.2±0.2

a. Papp is expressed in cm/sec (x 10-6). The values are means ± SEM. n=4.

5.5 Conclusion
This study is part of an ongoing exploration in our lab on the synthesis,
mechanisms and potential health effects of PMFs. PMFs have sparked interest due to
their wide spectrum of biological effects as an anti-inflammatory (Huang and Ho, 2010;
Lai et al., 2011; Li et al., 2007 a & b) and anti-carcinogenic (Morley et al., 2007, Pan et
al., 2007; Qui et al., 2011). Despite their health potential, the investigation on the
bioavailability of PMFs has lagged behind. This study provides some insight on the
cellular uptake of PMFs in HCT-116 colon cancer cells and the transport of these
compounds in a Caco-2 cell model.
The cellular uptake of PMF3, PMF4 and PMF7 in HCT-116 colon cancer cells
was observed and similar results were obtain in our lab when cellular uptake was
examined in another colon cell line, HT-29. Our lab has demonstrated that PMF3, PMF4
and PMF7 have strong inhibitory effects on the growth of the cancer cells in HCT-116,
which maybe in part due to their ability to easily be uptaken by the colon cancer cell
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lines. Our lab has also shown that these PMFs (3, 4 and 7) have different effects on the
cell cycle of colon cancer cells indicating that these three PMFs inhibit colon cancer cell
growth by different mechanisms (Qiu et al., 2010 & 2011). The number of methoxy
groups and their position may be the reason for why one PMF has higher intracellular
levels than another in HCT-116. It is plausible that there is a difference in preference by
the colon cancer cells line for uptake of certain PMFs. The exact mechanism by which
methoxylation may modulate the bioavailability of PMFs is a topic that warrants more
research.
Bioavailability of a compound is the amount of the compound that can reach the
blood circulatory system and target tissue (Van de Waterbeemd et al., 2003) . Walle and
his colleagues (Walle, 2007; Walle et al., 2007; Wen and Walle, 2006) have
demonstrated that methoxlyation of PMFs have higher hepatic metabolic stability and
intestinal absorption compared to unmethlated polyphenles. The low bioavaiability and
poor absorption of these unmethlated flavones is due to extensive conjugative
metabolism in the intestine and liver because of the free hydroxyl groups which gives rise
to rapid intestinal/hepatic conjugation and/or sulfation and excretion (Wen and Walle,
2006).
There has been investigations done on the in vitro absorption of nobiletin, a
PMF1, versus luteolin, a polyhydroxyflavonoid (unmethlyated), and results revealed that
nobiletin had higher permeability and accumulated in the differentiated Coc-2 cell
monolayer while luteolin did not (Murakami et al., 2001). Gres et al. (1998) reported if a
compound has a Papp values >2 × 10-6 cm/sec from Caco-2 cell model experiments then
the compound should be associated with efficient intestinal absorption. Therefore, PMF 3
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and PMF4 can be predicted to be associated with being able to be absorbed in the human
intestines, where PMF7 is less likely. More research is necessary to see what will occur if
concentrations are increased as well as what would occur if PMFs are placed in the
basolateral compartment.
In summary, the results in this study suggest PMFs have the potential to facilitate
intestinal absorption in vivo in human because of their capability to be transported in the
in vitro absorption Caco-2 cell model. Along with other results attained from our lab,
these observations demonstrate that PMFs as promising agents in cancer therapy and
prevention but future research efforts are needed to understand their mechanism of
transport.
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CHAPTER 6
FUTURE RESEACH
To compliment the research executed in this thesis, future work should continue
to focus on exploring the potential of methylated phytochemicals as cancer –fighting
compounds. Also, work ought to continue to utilize in vitro research models to evaluate
bioavailability of compounds. Furthermore, because of its sensitivity and high
selectivity, HPLC-EC should be evaluated for usage in the separation, identification, and
determination of other phytochemicals.
Based on the work done on the side-by-side comparison of resveratrol and
pterostilbene, pterostilbene had higher intracellular uptake on all three cancer cells
examined than resveratrol. Also, pterostilbene had stronger inhibition on the cell
viability on Caco-2 human colon cancer cells than resveratrol and similar results were
observed in other human colon cancer cells lines (Nutakul et al., 2011). This data
suggests that pterostilbene has superior anti-carcinogeic effect than resveratrol. Thus, it is
worth performing other side-by-side comparison of resveratrol and pterostilbene on other
cancer cells lines to see if similar results are obtained.
The preliminary experimentation preformed on certain PMFs revealed some new
insight on their bioavailability. They have different rates of transport but more research
is needed to determine what type of transport is occurring. Since transport experiments
on PMFs evaluated only the permeability of PMFs from the apical side to the basolateral
side, the next step would be to evaulate transport of PMFs from basolateral compartment
to apical compartment. This type of experiment could provide additional information on
the effect of secretory trasporters. Also, allows one to calculate the ratio of Papp B toA /
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Papp A to B (Papp basolateral compartment to apical compartment over Papp apical
compartment to basolateral compartment) for each PMF which would aid in determining
if efflux possiblity would occurr (Walle et al., 2003). Therefore, a better picture could
be drawn on the absorption of PMFs.
For all the compounds examined, determining the exact mechanism by which the
methoxylation effect intestinal absorption and modulates the bioavailability is an
attractive topic for future investigation. The natural progression would be to examine the
metabolism of these compounds and assess whether the metabolic products (metabolites)
have any biological and pharmacological properties. Knowledge of both a compounds
absorption and metabolism can aid in determining a compounds potential biological
functions in vivo (Masimirembwa et al., 2003; Mohutsky et al., 2006).
Bioavailability is an important factor that can dictate the efficacy of bioactive
dietary components. The bioavailability of a these compounds studied in this thesis can
be compromised in vivo because of their physicochemical properties, such as being
highly hydrophobic with poor solubility in both water and oil at body temperature.
Therefore, encapsulating and developing a delivery systems for these compounds would
aid in enhancing their bioavailability in vivo so bioactive compounds can reach the
intended target tissue.
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